APA

Greenspan S. L., Emkey R. D., Bone H. G., Weiss S. R., Bell N. H., Downs R. W., McKeever C., Miller S. S., Davidson M., Bolognese M. A., Mulloy A. L., Heyden N., Wu M., Kaur A. & Lombardi A. (20021217). Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial. : Annals of internal medicine.

Chicago

Greenspan Susan L, Emkey Ronald D, Bone Henry G, Weiss Stuart R, Bell Norman H, Downs Robert W, McKeever Clark, Miller Sam S, Davidson Michael, Bolognese Michael A, Mulloy Anthony L, Heyden Norman, Wu Mei, Kaur Amarjot and Lombardi Antonio. 20021217. Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial. : Annals of internal medicine.

Harvard

Greenspan S. L., Emkey R. D., Bone H. G., Weiss S. R., Bell N. H., Downs R. W., McKeever C., Miller S. S., Davidson M., Bolognese M. A., Mulloy A. L., Heyden N., Wu M., Kaur A. and Lombardi A. (20021217). Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial. : Annals of internal medicine.

MLA

Greenspan Susan L, Emkey Ronald D, Bone Henry G, Weiss Stuart R, Bell Norman H, Downs Robert W, McKeever Clark, Miller Sam S, Davidson Michael, Bolognese Michael A, Mulloy Anthony L, Heyden Norman, Wu Mei, Kaur Amarjot and Lombardi Antonio. Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial. : Annals of internal medicine. 20021217.